Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsaleh

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Gastroenterology and Hepatology|August 4, 2009
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?Hany Elsaleh, James J Farrell, Christopher H Crane
British Journal of Cancer|September 15, 2001
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilB Iacopetta, F Grieu, D Joseph, et al.
The Journal of Pathology|December 18, 2001
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancerG Gnanasampanthan, H Elsaleh, K McCaul, et al.
Australasian Radiology|September 7, 2000
Small cell carcinoma of the vaginaH Elsaleh, S Bydder, B Cassidy, et al.
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Early detection markers in Pancreas CancerJames J Farrell, Marius van Rijnsoever, Hany Elsaleh
Lancet (London, England)|November 10, 2000
Breast cancer survival advantage with radiotherapyS Bydder, N Spry, D J Joseph, et al.
The Australian and New Zealand Journal of Surgery|October 20, 1999
Pre-operative chemoradiotherapy in locally advanced rectal cancerH Elsaleh, D Joseph, M Levitt, et al.
Hematology/Oncology Clinics of North America|April 4, 2006
Radiation modifiers: treatment overview and future investigationsC T Thomas, A Ammar, J J Farrell, et al.
International Journal of Oncology|November 24, 1999
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomasH Elsaleh, P Soontrapornchai, F Grieu, et al.
Australasian Radiology|September 5, 2001
Choroid plexus carcinoma in an adultS S Wyatt, R A Price, D Holthouse, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Gastroenterology and Hepatology|August 4, 2009
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?Hany Elsaleh, James J Farrell, Christopher H Crane
British Journal of Cancer|September 15, 2001
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilB Iacopetta, F Grieu, D Joseph, et al.
The Journal of Pathology|December 18, 2001
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancerG Gnanasampanthan, H Elsaleh, K McCaul, et al.
Australasian Radiology|September 7, 2000
Small cell carcinoma of the vaginaH Elsaleh, S Bydder, B Cassidy, et al.
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Early detection markers in Pancreas CancerJames J Farrell, Marius van Rijnsoever, Hany Elsaleh
Lancet (London, England)|November 10, 2000
Breast cancer survival advantage with radiotherapyS Bydder, N Spry, D J Joseph, et al.
The Australian and New Zealand Journal of Surgery|October 20, 1999
Pre-operative chemoradiotherapy in locally advanced rectal cancerH Elsaleh, D Joseph, M Levitt, et al.
Hematology/Oncology Clinics of North America|April 4, 2006
Radiation modifiers: treatment overview and future investigationsC T Thomas, A Ammar, J J Farrell, et al.
International Journal of Oncology|November 24, 1999
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomasH Elsaleh, P Soontrapornchai, F Grieu, et al.
Australasian Radiology|September 5, 2001
Choroid plexus carcinoma in an adultS S Wyatt, R A Price, D Holthouse, et al.
Pageof 7